Azitra, Inc. Announces Q3 2025 Results and Provides Business Updates [Yahoo! Finance]
Azitra Inc (AZTR)
Company Research
Source: Yahoo! Finance
focused on developing innovative therapies for precision dermatology, today reported financial results for the quarter ended September 30, 2025, and provided a business update. Azitra Logo (PRNewsfoto/Azitra, Inc.) Q3 2025 and Recent Business Highlights Dosed first patient in Phase 1/2 trial for ATR-04 program targeting oncology patients with EGFRi-associated rash in August 2025 Presented positive preclinical data at BIO-Europe® for ATR-01 program, targeting the treatment of ichthyosis vulgaris Raised $2.8M in gross proceeds through our established equity line of credit with institutional investor Alumni Capital LP "The third quarter of 2025 was an impactful period for Azitra as we continued to progress our live biotherapeutic programs, including dosing the first patient in our Phase 1/2 trial for ATR-04 targeting oncology patients with EGFRi-associated rash," said Francisco Salva, CEO of Azitra. "This candidate previously received Fast Track designation from the FDA as th
Show less
Read more
Impact Snapshot
Event Time:
AZTR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZTR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZTR alerts
High impacting Azitra Inc news events
Weekly update
A roundup of the hottest topics
AZTR
News
- Azitra, Inc. to Present at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare ConferencePR Newswire
- Azitra Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American [Yahoo! Finance]Yahoo! Finance
- Azitra receives NYSE American approval of listing compliance plan [Seeking Alpha]Seeking Alpha
- Azitra Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE AmericanPR Newswire
- Azitra, Inc. Announces Pricing of $1.5 Million Private Placement Priced At a Premium To Market Under NYSE RulesPR Newswire
AZTR
Sec Filings
- 1/30/26 - Form S-8
- 1/2/26 - Form DEF
- 12/23/25 - Form PRE
- AZTR's page on the SEC website